Knowledge of RNR's allosteric regulation is also relevant for cancer therapy since many of the currently used anticancer drugs, including gemcitabine, cladribine, fludarabine and clofarabine, mimic the natural substrates and allosteric effectors of this enzyme (Nocentini, 1996; Parker et al., 1991). The gene discussed is NR2E3; the disease is cancer.